The numbers are all heading in the right direction. Seems like the tough decisions made over the last year or two are paying off. If they can maintain revenue growth of 38% for the next half and keep costs the same they’re pretty much at break even.
- Forums
- ASX - By Stock
- UBN
- Ann: Investor Presentation - 1H19 Results
Ann: Investor Presentation - 1H19 Results, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UBN (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.38M |
Open | High | Low | Value | Volume |
44.0¢ | 44.0¢ | 44.0¢ | $9 | 21 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9902 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.430 |
1 | 4761 | 0.410 |
1 | 20000 | 0.350 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 271 | 2 |
0.450 | 25000 | 1 |
0.455 | 5364 | 1 |
0.460 | 13333 | 1 |
0.520 | 15069 | 1 |
Last trade - 15.48pm 25/11/2024 (20 minute delay) ? |
Featured News
UBN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online